Four things to know:
1. In 2019, the market was valued at $1.1 billion.
2. A rise in approvals and product launches is expected to boost the market during the forecast period.
3. Recent developments in the market include Centinel Spine gaining FDA approval for a two-level clinical trial of its Prodisc C anterior cervical total disc devices and Zimmer Biomet launching its Mobi-C cervical disc in Japan.
4. Ongoing clinical trials for the treatment of degenerative disc disease is contributing to the growth of the Asia Pacific market.
More articles on devices:
Dr. Daniel Yoshor excited by new challenge at Penn Medicine
New York neurosurgeon recovers from COVID-19, volunteers at hospital ICU
Neurosurgeon, dentist’s 3D printed masks evolved production, being made worldwide: 5 details
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
